← All trials
NCT04521413
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Jun 30, 2024
- First posted
- Aug 20, 2020
- Last posted
- Oct 12, 2020
- Enrollment
- 170
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Treadwell Therapeutics, IncLead sponsor
- SCRI Development InnovationsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.